Covant Therapeutics is a Boston-based covalent drug discovery company that was incubated by Roivant Sciences. Covant creates novel therapeutics by using covalency to imprint and regulate proteins. To discover these therapeutics, the company applies cutting-edge capabilities and expertise in chemistry, quantitative proteomics, translational sciences, and deep learning.